- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Contraceptives market was valued at 2000 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.7% during the forecast period.
This report presents the market size and development trends by detailing the Contraceptives market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Contraceptives market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Contraceptives industry and will help you to build a panoramic view of the industrial development.
Contraceptives Market, By Type:
Drugs
Devices
Contraceptives Market, By Application:
Male
Female
Some of the leading players are as follows:
SMB
Johnson & Johnson
Bayer HealthCare
Actavis
Mayer Laboratories
The Female Health Company
Church & Dwight
Merck
Zizhu Pharm
Reckitt Benckiser
Pfizer
Karex Berhad.
Cheung Kong Biopharmaceuticals
CooperSurgical
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Contraceptives Market: Technology Type Analysis
-
4.1 Contraceptives Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Contraceptives Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Drugs
4.3.2 Devices
5 Contraceptives Market: Product Analysis
-
5.1 Contraceptives Product Market Share Analysis, 2018 & 2026
-
5.2 Contraceptives Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Contraceptives Market: Application Analysis
-
6.1 Contraceptives Application Market Share Analysis, 2018 & 2026
-
6.2 Contraceptives Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Male
6.3.2 Female
7 Contraceptives Market: Regional Analysis
-
7.1 Contraceptives Regional Market Share Analysis, 2018 & 2026
-
7.2 Contraceptives Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 SMB
9.1.1 SMB Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Johnson & Johnson
9.2.1 Johnson & Johnson Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Bayer HealthCare
9.3.1 Bayer HealthCare Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Actavis
9.4.1 Actavis Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Mayer Laboratories
9.5.1 Mayer Laboratories Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 The Female Health Company
9.6.1 The Female Health Company Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Church & Dwight
9.7.1 Church & Dwight Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Merck
9.8.1 Merck Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Zizhu Pharm
9.9.1 Zizhu Pharm Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Reckitt Benckiser
9.10.1 Reckitt Benckiser Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Pfizer
9.11.1 Pfizer Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Karex Berhad.
9.12.1 Karex Berhad. Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Cheung Kong Biopharmaceuticals
9.13.1 Cheung Kong Biopharmaceuticals Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 CooperSurgical
9.14.1 CooperSurgical Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
The List of Tables and Figures (Totals 105 Figures and 159 Tables)
Figure Drugs Contraceptives market, 2015 - 2026 (USD Million)
Figure Devices Contraceptives market, 2015 - 2026 (USD Million)
Figure Male market, 2015 - 2026 (USD Million)
Figure Female market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Contraceptives market, by country, 2015 - 2026 (USD Million)
-
Table North America Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table North America Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table North America Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Canada Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Canada Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Europe Contraceptives market, by country, 2015 - 2026 (USD Million)
-
Table Europe Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Europe Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Europe Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Germany Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Germany Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table France Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table France Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Italy Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Italy Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Spain Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Spain Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Contraceptives market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table China Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table China Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Japan Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Japan Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table India Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table India Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Contraceptives market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table MEA Contraceptives market, by country, 2015 - 2026 (USD Million)
-
Table MEA Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table MEA Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table MEA Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Contraceptives market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Contraceptives market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Contraceptives market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table SMB Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer HealthCare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Actavis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mayer Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table The Female Health Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Church & Dwight Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zizhu Pharm Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Reckitt Benckiser Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Karex Berhad. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cheung Kong Biopharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CooperSurgical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-